Retatrutide 10mg has not been evaluated or approved by Health Canada for human use
In terms of dosing, we follow the same dosing titration schedule as name brand medications (like Ozempic & Wegovy)
Recent clinical trials and meta-analyses from 2022 to 2025 show significant results validating the efficacy and safety of this medication for weight loss
In rare cases, acute hepatitis B can cause liver failure
For instance, the subcutaneously injected drug Semaglutide 2.4 mg, approved in 2021 and administered once a week, has been shown to achieve an average weight reduction of 15%-17% and also offers cardiovascular protective effects
Esta es la dosis con la que continuars una vez que alcances tu peso objetivo, o ests a punto de alcanzarlo, y quieras estabilizar tu peso hasta que decidas finalizar el tratamiento